Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Jazz Pharmaceuticals plc (NASDAQ: JAZZ)
JAZZ Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-91.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
6.80%
JAZZ Stock Analysis
JAZZ
PE Ratio:
2099.4
JAZZ
PEG Ratio:
Not Available
JAZZ
Forward EPS Growth (12 month):
0.00%
JAZZ
PS Ratio:
3.3
JAZZ
PSG Ratio:
Not Available
JAZZ
Forward Revenue Growth (12 month):
0.00%
JAZZ Articles
No data was found